Olivia Miller
Dermatology · Dillon, SCNPI 1023639853
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.0%), speaking fees and education — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Galderma Laboratories, L.p. at 50.7% of the total. 2025 is the largest year on record at $5,657, 6.3 times the $902 reported in 2021.
Across 224 payments — averaging $43.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$5K
- AbbVie$887
- Regeneron Healthcare Solutions, Inc.$663
- Sanofi$619
- Johnson & Johnson$553
- Sun Pharmaceutical Industries Inc.$324
- plus $2K from 23 others
What the payments were for
- Speaking & faculty fees$4,35045%
- Travel & lodging$3864%
- Food & beverage$4,45546%
- Education$4885%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 9 | $4,905 |
| AbbVie | 31 | $887 |
| Regeneron Healthcare Solutions, Inc. | 35 | $663 |
| Sanofi | 37 | $619 |
| Johnson & Johnson | 29 | $553 |
| Sun Pharmaceutical Industries Inc. | 15 | $324 |
| E.r. Squibb & Sons, L.L.C. | 6 | $251 |
| LEO Pharma Inc. | 4 | $165 |
| UCB, Inc. | 9 | $158 |
| Atricure, Inc. | 1 | $136 |
| Amgen | 5 | $108 |
| Beone Medicines USA, Inc. | 4 | $105 |
| Dermavant Sciences, Inc. | 3 | $85 |
| Biofrontera Inc. | 5 | $83 |
| Incyte Corporation | 4 | $75 |
| Lilly USA, LLC | 4 | $67 |
| Misonix Inc | 1 | $65 |
| Novartis | 3 | $58 |
| Organon | 3 | $58 |
| Pfizer | 3 | $51 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $49 |
| Sobi, Inc | 1 | $46 |
| Janssen Scientific Affairs, LLC | 1 | $38 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $27 |
| Journey Medical Corporation | 1 | $24 |
| Tempus AI, Inc | 1 | $24 |
| Mayne Pharma Commercial LLC | 2 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| Strata Skin Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEMLUVIO$4,736
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$136
- Humira$117
- ENSTILAR$112
- Sotyktu$108
How this compares
$9,679 in reported general payments places this provider in the 75th percentile of 203 dermatology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 70 | $262,018 |
| ZoryveRoflumilast | 14 | $13,205 |
| Fluorouracil | 94 | $6,486 |
| Ketoconazole | 319 | $6,010 |
| Tacrolimus | 50 | $5,758 |
| Clobetasol Propionate | 121 | $4,915 |
| Metronidazole | 88 | $4,624 |
| Azelaic Acid | 37 | $3,189 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 149 | $2,938 |
| Clindamycin Phosphate | 90 | $2,915 |
| Mupirocin | 361 | $2,534 |
| Triamcinolone Acetonide | 209 | $2,083 |
| Mometasone Furoate | 63 | $1,395 |
| Doxycycline Hyclate | 86 | $1,269 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 16 | $1,097 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Arcutis Biotherapeutics, Inc.Zoryve | $17 | $13,20514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 203 dermatology providers in South Carolina.
Other dermatology in Dillon
- Marshall ShulerGreenville$2.6M
- Rebecca SmithFort Mill$2.3M
- Todd SchlesingerCharleston$1.9M
- Amylynne FrankelSpartanburg$987K
- Marguerite GermainMt Pleasant$200K
- George KeoughPawleys Island$150K
- Christopher MartinAbbeville$129K
- Lee CarsonGreenville$127K
- Mark SiegelCharleston$120K
- Jeffrey SmithWest Columbia$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.